Drugs

Narcan, the naloxone nasal spray used to reverse opioid overdose, was just FDA-approved for over-the-counter sale—a major victory for harm reduction advocates and public health. 

Insulin manufacturer Eli Lilly follows the government’s lead with a $35 price cap. Will manufacturers follow suit?

Thanks to a loophole in the FDA’s drug advertising regulations, some companies are marketing misleading and unproven treatments unchecked—and putting vulnerable populations seeking cures at risk.

Spanning 7 countries, a major piece of global maternal health research found that a low-cost, widely available generic antibiotic can prevent life-threatening sepsis during childbirth in women delivering babies in low- and middle-income countries.  

Analysis found that more than two-thirds of top-selling prescription drugs in U.S.—one of two countries that allows direct marketing to consumers—were rated as having low added benefit compared to other drugs in 2020.